Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Topaz Pharmaceuticals’ Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs

July 11, 2011 By Bio-Medicine.Org

HORSHAM, Pa., July 11, 2011 /PRNewswire/ — In a study sponsored
by Topaz Pharmaceuticals Inc., a privately held specialty
pharmaceutical company, scientists from the University of
Massachusetts, Amherst presented data showing that a 0.5%
ivermectin (IVM) cream formulation was active against lice eggs
from permethrin resistant head lice.  The data were presented
in a poster presentation on Saturday, July 9, 2011 at the 37th Annual
Meeting of the Society for Pediatric Dermatology
in Baltimore,
Maryland.  

“These data build on our earlier work showing this ivermectin
formulation is active against head lice,” said John M. Clark,
Ph.D., Professor of Veterinary and Animal Sciences, University of
Massachusetts Amherst.  “The data suggest that a single
treatment with 0.5% ivermectin cream has the potential to fully
break the head louse life cycle.   If approved by the FDA,
ivermectin cream has the potential to provide physicians with an
attractive treatment option.”  

In the study, permethrin resistant head lice were allowed to lay
eggs in tufts of human hair.  Adult lice were removed and the
tufts with eggs were exposed to 0.5% ivermectin cream, to vehicle
only, or to unformulated, diluted ivermectin. After a 10-minute
exposure, tufts were thoroughly rinsed and incubated.  Any
hatched lice were placed onto new tufts and moved to a feeding cup.
 The hatchability of treated eggs was not affected by
ivermectin. No differences were detected between the mortality rate
of eggs exposed to 0.5% ivermectin cream and those exposed to
unformulated ivermectin.  The percent of hatched lice from
eggs exposed to 0.5% ivermectin cream that took a blood meal,
relative to eggs exposed to placebo, was significantly decreased
(by 82-95%).  All hatched lice from eggs treated with 0.5%
ivermectin cream died within 48 hours.  

About Ivermectin

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech